Evidence
Rev Med Suisse. 2023 Apr 26;19(824):807-809. doi: 10.53738/REVMED.2023.19.824.807.
ABSTRACT
Cerebral amyloid angiopathy (CAA) is a common and well-defined small vessel disease characterized by the deposition of amyloid β in the vascular wall. CAA causes devastating outcomes related to intracerebral hemorrhage and cognitive decline in older adults. The shared pathogenic pathway between CAA and Alzheimer’s disease, co-occuring frequently in the same subject, has important implications for cognitive outcomes and novel anti-amyloid-β immunotherapies. In this review, we present the epidemiology, pathophysiology, current diagnostic criteria of CAA, and future developments in the field.
PMID:37133940 | DOI:10.53738/REVMED.2023.19.824.807
Add to Google Keep
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Cerebral amyloid angiopathy-related cognitive decline: small vessels, big problems
🌐 90 Days
VR Related Evidence Matrix
- Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats
- Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities
- Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study
- Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy
- Surgical intervention for cerebral amyloid angiopathy-related lobar intracerebral hemorrhage: a systematic review
- Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy
- The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy
- The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease
- D’un suicide à l’autre ?
- Violence envers les soignants : l’augmentation des primes a cristallisé les tensions
- Attention deficit disorder with/without hyperactivity and obesity in adolescence
- Atherosclerotic burden and cerebral small vessel disease: exploring the link through microvascular aging and cerebral microhemorrhages
- Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico-pathological study
- Digital environment and population health
- Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
- Swiss healthcare system: a bulimic machine
- Decreased microvascular claudin-5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhage
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Association of Alzheimer's Disease and Other Neuropathologies with Functional Disability in Persons With and Without Dementia
- Aspiration pneumonia and dementia in nursing homes: to anticipate emergency.
- Hypnosis: a complementary tool for managing adolescents affected by anorexia nervosa
- Physical and Psychosocial Benefits of Sports Participation Among Children and Adolescents with Chronic Diseases: A Systematic Review
- Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition
- Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition
- Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort
- Cognition and Amyloid-b in Older Veterans: Characterization and Longitudinal Outcomes of Data-Derived Phenotypes
- Cognition and Amyloid-b in Older Veterans: Characterization and Longitudinal Outcomes of Data-Derived Phenotypes
- Pathophysiology of cerebral small vessel disease: a journey through recent discoveries
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)
- Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients
- Peripheral hearing loss at age 70 predicts brain atrophy and associated cognitive change
- Novel insights into presenilin 1 mutation associated with a distinctive dementia phenotype and cotton wool plaques
- Genetic Determinants of Vascular Dementia
- Specific Association of Worry With Amyloid-β But Not Tau in Cognitively Unimpaired Older Adults
- Multi-night acoustic stimulation is associated with better sleep, amyloid dynamics, and memory in older adults with cognitive impairment
- Is Alzheimer disease a disease?
- Quantitative Brain Amyloid PET
- A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer's Disease Risk in Older Men with Prostate Cancer
- Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy
- Small-vessel disease in the brain
- Plasma Leptin and Alzheimer Protein Pathologies Among Older Adults
- Vitamin D, Alzheimer's disease and related dementia
- Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?
- Passive immunotherapy for Alzheimer's disease: challenges & future directions
- Disentangling Sex-Dependent Effects of APOE on Diverse Trajectories of Cognitive Decline in Alzheimer's Disease
- Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Association between retinal microvascular abnormalities and late-life brain amyloid-b deposition: the ARIC-PET study
- Spatial navigation questionnaires as a supportive diagnostic tool in early Alzheimer's disease
- Dominant CST3 variants cause adult onset leukodystrophy without amyloid angiopathy
- Cognitive and neuroscientific perspectives of healthy ageing
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
- Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review
- Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review
- Clinical predictors of Alzheimer's disease-like brain atrophy in individuals with memory complaints
- Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET
- The vascular contribution of apolipoprotein E to Alzheimer's disease
- Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
- Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age-Results from the Multicentre Observational DELCODE Study
- Bacteroidota inhibit microglia clearance of amyloid-beta and promote plaque deposition in Alzheimer's disease mouse models
- Using Drosophila amyloid toxicity models to study Alzheimer's disease
- Ageing-Related Neurodegeneration and Cognitive Decline
Evidence Blueprint
Cerebral amyloid angiopathy-related cognitive decline: small vessels, big problems
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Cerebral amyloid angiopathy-related cognitive decline: small vessels, big problems
🌐 365 Days
VR Related Evidence Matrix
- Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats
- Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease
- Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities
- Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy
- Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology
- Treatment of the CRND8 mouse model for cerebral amyloid angiopathy, exhibited increased levels of neuron specific enolase in brain tissue following long-term treatment with a modified C5a receptor agonist, accompanied by improved cognitive function
- Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study
- Analysis of the prevalence of anticoagulant therapy in patients with cognitive disorders and cerebral amyloid angiopathy (CAA)
- Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer's disease
- The histopathological correlates of lobar microbleeds in false-positive cerebral amyloid angiopathy cases
- Cerebral Amyloid Angiopathy and Risk of Isolated Nontraumatic Subdural Hemorrhage
- Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy
- O-GalNAc glycosylation determines intracellular trafficking of APP and Aβ production
- Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease
- Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy-related inflammation: a systematic analysis of published and seven new cases
- Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia
- Surgical intervention for cerebral amyloid angiopathy-related lobar intracerebral hemorrhage: a systematic review
- Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy
- The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy
- Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormone
- The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease
- Sex-Specific Patterns of Cerebral Atrophy and Enlarged Perivascular Spaces in Patients with Cerebral Amyloid Angiopathy and Dementia
- Untangling Alzheimer's disease with spatial multi-omics: a brief review
- D’un suicide à l’autre ?
- Violence envers les soignants : l’augmentation des primes a cristallisé les tensions
- Assistance au suicide : la spiritualité, à la fois un soutien et une contrainte
- Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy
- Neuropathologic correlates of cerebral microbleeds in community-based older adults
- Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia: Dementia Series
- Endothelial leakiness elicited by amyloid protein aggregation
- Integrative medicine and geriatrics : towards a convergence?
- Do we all suffer from imposter syndrome?
- Stockholm Syndrome and controlling relationships: to understand and act
- Attention deficit disorder with/without hyperactivity and obesity in adolescence
- Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample
- Atherosclerotic burden and cerebral small vessel disease: exploring the link through microvascular aging and cerebral microhemorrhages
- Emergency management of patients with autism spectrum disorder
- Borderline psychiatric disorder in the general hospital : specificity and clinical challenges
- Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico-pathological study
- In-hospital withdrawal of benzodiazepines in long term users : a bad idea with good intentions
- Digital environment and population health
- A patient-researcher in psychiatry: the role of lived experience in the production of knowledge
- The end of dialysis: the weariness to carry on
- Non-Alcoholic Fatty Liver Disease and Diabetes: the bad marriage
- Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
- New horizons in the diagnosis and management of Alzheimer's Disease in older adults
- Swiss healthcare system: a bulimic machine
- Decreased microvascular claudin-5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhage
- Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
- Longitudinal changes in hippocampal texture from healthy aging to Alzheimer's disease
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Asthma: a respiratory pathology with a high risk for mental health
- Association of Alzheimer's Disease and Other Neuropathologies with Functional Disability in Persons With and Without Dementia
- The supersaturation perspective on the amyloid hypothesis
- Utility of amyloid PET Imaging in a Memory Clinic
- Aspiration pneumonia and dementia in nursing homes: to anticipate emergency.
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Hypnosis: a complementary tool for managing adolescents affected by anorexia nervosa
- Patterns of amyloid accumulation in amyloid-negative cases
- Physical and Psychosocial Benefits of Sports Participation Among Children and Adolescents with Chronic Diseases: A Systematic Review
- Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
- Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition
- Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition
- Cerebrovascular disease lesions are additive and tied to vascular risk factors and cognitive impairment